APOE and dementia: We found consistent results when dementia‐related prescriptions without a corresponding dementia diagnostic code and postconcussion syndrome cases were removed from the phenotyping algorithm, further strengthening the findings, particularly for the APOE4 homozygote groups (Table S2).